Urofollitropin FSH for injection
Fertility Treatment & Assisted Reproduction
A refined type of follicle-stimulating hormone (FSH) used in fertility treatments is called urofollitropin FSH for injection. In women undergoing assisted reproductive treatments like in vitro fertilization (IVF), it is essential for promoting ovarian follicle development and increasing the likelihood of successful conception.
Product Introduction
▸ CAS Number: 97048-13-0
▸ Standard: In-house
Urofollitropin is a critical component in fertility treatments, helping many individuals and couples achieve pregnancy when other methods have not been successful.
Applications
Urofollitropin is a highly purified form of follicle-stimulating hormone (FSH), which plays a critical role in fertility treatments. FSH is a gonadotropin, a type of hormone that is essential for the development of eggs in the ovaries of women and sperm in the testes of men. Urofollitropin is derived from the urine of postmenopausal women, who naturally have higher levels of this hormone due to the cessation of their reproductive cycles. This hormone is primarily used to stimulate the ovaries in women undergoing assisted reproductive technologies, such as in vitro fertilization (IVF).
Administration
Urofollitropin is typically administered via subcutaneous (under the skin) or intramuscular (into the muscle) injection. The dosages and duration of treatment are tailored to each individual based on their response to the medication and the specific treatment protocol being used.
Clinical Use
This medication is used in women with ovulation disorders, those who do not produce enough endogenous FSH, or those undergoing controlled ovarian hyperstimulation for assisted reproductive technologies. It helps in cases where natural ovulation is not occurring or is insufficient for achieving pregnancy.
Side Effects
Common side effects of urofollitropin include:
▸Abdominal discomfort and bloating
▸ Headache
▸ Injection site reactions (redness or swelling)
A serious but rare side effect is ovarian hyperstimulation syndrome (OHSS), which can cause severe abdominal pain, nausea, vomiting, and rapid weight gain. OHSS requires immediate medical attention.
Monitoring
Patients receiving urofollitropin are closely monitored through blood tests and ultrasound to assess follicle development and minimize the risk of OHSS. This careful monitoring helps ensure that the ovaries are responding appropriately to the treatment and reduces the risk of complications.
Conclusion
Urofollitropin is a critical component in fertility treatments, enabling many individuals and couples to achieve pregnancy when other methods have not been successful. Its role in stimulating the ovaries to produce multiple eggs is vital for the success of procedures like IVF, providing hope and opportunities for those facing fertility challenges.
Hot Tags: urofollitropin fsh for injection, China urofollitropin fsh for injection manufacturers, suppliers, factory, Atosiban, Oxitocina Humana, Human Chorionic Gonadotropin, Gonadotropina Menop usica Humana, 37025-55-1, Urokinase
